Han, Xiaohong
Han, Ying
Tan, Qiaoyun
Huang, Yu
Yang, Jianliang
Yang, Sheng
He, Xiaohui
Zhou, Shengyu
Song, Yan
Pi, Jinping
Zuo, Lijie
Yao, Jiarui
Wu, Di
Zhang, Zhishang
Shi, Yuankai https://orcid.org/0000-0002-3342-4964
Funding for this research was provided by:
Chinese National Major Project for New Drug Innovation (2017ZX09304015)
Chinese National Major Project for New Drug Innovation (2019ZX09201002)
National Natural Science Foundation of China (81871739)
National Natural Science Foundation of China (81472752)
CAMS Innovation Fund for Medical Sciences (2016-I2M-1-001)
Article History
Received: 7 July 2019
Accepted: 25 September 2019
First Online: 10 October 2019
Ethics approval and consent to participate
: This is a retrospective study in nature. The study was approved by the Independent Review Board (IRB) of Cancer Hospital, Chinese Academy of Medical Sciences and BGI Genomics (CH-BMS-018, BGI-IRB18035).
: Not applicable.
: The authors declare that they have no competing interests.